Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07468279 · ClinicalTrials.gov registry record · NA

Synchronization of Theta to Influence Memory

A NA study of Memory and Cognitive Control, sponsored by Florida International University.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT07468279: Recruiting NA study of Memory and Cognitive Control, sponsored by Florida International University.

NCT07468279 is a NA study of Memory and Cognitive Control that is actively recruiting participants, run by Florida International University. The registered enrollment target is 90 participants, above the 69-participant average among 15 other Memory trials with a reported enrollment target (30% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07468279, a NA study of Memory and Cognitive Control, is actively recruiting participants, sponsored by Florida International University.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

This study aims to clarify relations between brain oscillations and two cognitive functions: cognitive control and memory.

Primary Outcome

The hit rate for faces that appeared on error trials minus the hit rate for faces that appeared on correct trials.

Conditions Studied

Interventions

  • DEVICE Sham device
  • DEVICE STARSTIM Device in-phase
  • DEVICE STARSTIM Device anti-phase

Study Locations (1)

Florida

  • Florida International University - Miami

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2026-03-13
Est. Completion 2031-01
Phase NA
Florida International University

89 total trials

What NCT07468279 shows while recruiting

NCT07468279 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, above the 69-participant average among 15 other Memory trials with a reported enrollment target (30% higher).

The record links to 2 conditions, with Memory appearing as the primary indexed condition, and to 3 interventions - of which Sham device is the first listed.

NCT07468279 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT07468279 about?

NCT07468279 is a clinical study titled "Synchronization of Theta to Influence Memory". This study aims to clarify relations between brain oscillations and two cognitive functions: cognitive control and memory.

What is the current status of trial NCT07468279?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2026-03-13. Estimated completion is 2031-01.

What conditions does trial NCT07468279 study?

This clinical trial studies the following conditions: Memory, Cognitive Control.

What interventions are being tested in trial NCT07468279?

The interventions under investigation include: Sham device (DEVICE), STARSTIM Device in-phase (DEVICE), STARSTIM Device anti-phase (DEVICE).

Who is sponsoring clinical trial NCT07468279?

This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07468279 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Memory

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07468279's enrollment target sits among peer trials

90 4th of 15 higher than 12 of 15 other Memory trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Memory trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07468279, the US trial registry maintained by the National Library of Medicine. NCT07468279 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.